STRS Ohio’s 4D Molecular Therapeutics FDMT Stock Holding History

STRS Ohio’s Portfolio FDMT Stock Details FDMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$234K	Hold	25,100	–	–	﹤0.01%	1427
2025 Q4	$188K	Hold	25,100	–	–	﹤0.01%	1550
2025 Q3	$218K	Buy	+25,100	New	+$150K	﹤0.01%	1490
2021 Q2	–	Sell	-1,900	Closed	-$82K	–	2289
2021 Q1	$82K	Buy	+1,900	New	+$84.1K	﹤0.01%	1976

Other funds holding FDMT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

STRS Ohio's FDMT Position: Q1 2026 in Review

STRS Ohio held its 4D Molecular Therapeutics (FDMT) position steady in Q1 2026 at 25,100 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

STRS Ohio first reported a position in FDMT in Q1 2021 and has held it in 4 quarters since. 152 funds tracked by Wall St. Rank hold FDMT as of Q1 2026.

STRS Ohio held 25,100 shares of 4D Molecular Therapeutics worth $234K as of Q1 2026.
STRS Ohio left its 4D Molecular Therapeutics share count unchanged in Q1 2026.
4D Molecular Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1427 holding.
STRS Ohio first reported a position in 4D Molecular Therapeutics in Q1 2021 and has held it in 4 quarters since.
152 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.